Clinical Trials

A Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy Vs. Observation in Patients with Residual Triple-Negative Basal-Like Breast Cancer following Neoadjuvant Chemotherapy


Study ID
ECOG-ACRIN EA1131

NCT Number
NCT02445391 (Click on the NCT number for more information about the trial)

Research Study Number
00005915

Principle Investigator
Dr. Donna McNamara

Phase
III

Sponsor
ECOG-ACRIN


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now